Latest filing published 09 Sept 2024 for Idexx Laboratories INC /de. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jonathan W. Ayers (board member) discloses dealings in Idexx Laboratories INC /de to SEC (Form 4). In total, 31 filings cover trades dated from 10 May 2021 to 6 September 2024.
Every open-market trade on record is a sale: 2 sales worth €227k. The totals exclude 1 filing filed without an amount. Other entries cover 8 option exercises.
The latest filing, published on 9 September 2024, reports a transaction in Idexx Laboratories INC /de. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations